Top Markets
Coin of the day
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
주식 순위 #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
주가
$0.2488447
마지막 동기화: 2024-10-01
시가총액
$2.01M
변동 (1일)
-1.88%
변동 (1년)
0.00%
국가
IN
거래 Ortin Laboratories Limited (ORTINLAB)

카테고리

Ortin Laboratories Limited (ORTINLAB)의 수익
Jun 2024 기준 수익 TTM: $-862.73K
Ortin Laboratories Limited의 최신 재무 보고서에 따르면 회사의 현재 수익은 $-862.73K입니다. 2023년에 회사는 $-10.20K의 수익을 올렸으며 이는 2022년의 수익 $-69.81K과 증가입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Ortin Laboratories Limited의 수익 기록 (2008 ~ 2026)
연말 수익
연도 수익 변화
2026 (TTM) $-862.73K 1.68%
2024 $-848.51K 8,221.19%
2023 $-10.20K -85.39%
2022 $-69.81K -474.55%
2021 $18.64K -80.46%
2020 $95.37K -63.97%
2019 $264.69K 153.29%
2018 $104.50K -33.59%
2017 $157.35K -25.29%
2016 $210.63K -1.43%
2015 $213.68K -23.89%
2014 $280.75K -17.87%
2013 $341.84K -33.53%
2012 $514.27K 8.07%
2011 $475.88K 64.44%
2010 $289.39K 48.21%
2009 $195.26K -47.62%
2008 $372.80K 0.00%
유사 기업 또는 경쟁사의 수익